Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G

Molecular Cancer Therapeutics

Volumn 1, Issue 10, 2002, Pages 803-809

  Deguchi, Atsuko ^a   Soh, Jae Won ^a   Li, Han ^b   Pamukcu, Rifat ^b   Thompson, W Joseph ^b   Weinstein, I Bernard ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b Cell Pathways Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CP 461; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; DRUG DERIVATIVE; ENZYME INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PHOSPHOPROTEIN; SULINDAC; SULINDAC SULFONE; VASODILATOR STIMULATED PHOSPHOPROTEIN; VASODILATOR-STIMULATED PHOSPHOPROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL STRAIN COS1; DRUG ANTAGONISM; ENZYME ACTIVATION; HUMAN; METABOLISM; MUTATION; PHOSPHORYLATION; TIME; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; COS CELLS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MICROFILAMENT PROTEINS; MUTATION; PHOSPHODIESTERASE INHIBITORS; PHOSPHOPROTEINS; PHOSPHORYLATION; SULINDAC; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0036690669     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Eigenthaler, M., Lohmann, S. M., Walter, U., and Pilz, R. B. Signal transduction by cGMP-dependent protein kinases and their emerging roles in the regulation of cell adhesion and gene expression. Rev. Physiol. Biochem. Pharmacol., 135: 173-209, 1999.
2. Vaandrager, A. B., and de Jonge, H. R. Signalling by cGMP-dependent protein kinases. Mol. Cell. Biochem., 157: 23-30, 1996. (Pubitemid 26142433)
3. Shimojo, T., Hiroe, M., Ishiyama, S., Ito, H., Nishikawa, T., and Marumo, F. Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. Exp. Cell Res., 247: 38-47, 1999. (Pubitemid 29393960)
4. Loweth, A. C., Williams, G. T., Scarpello, J. H., and Morgan, N. G. Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line, HIT-T15. FEBS Lett., 400: 285-288, 1997. (Pubitemid 27039368)
5. Chiche, J. D., Schlutsmeyer, S. M., Bloch, D. B., de la Monte, S. M., Roberts, J. D., Jr., Filippov, G., Janssens, S. P., Rosenzweig, A., and Bloch, K. D. Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J. Biol. Chem., 273: 34263-34271, 1998.
6. Stacey, P., Rulten, S., Dapling, A., and Phillips, S. C. Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). Biochem. Biophys. Res. Commun., 247: 249-254, 1998. (Pubitemid 28420808)
7. Smolenski, A., Burkhardt, A. M., Eigenthaler, M., Butt, E., Gambaryan, S., Lohmann S. M., and Walter, U. Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects. Naunyn-Schmiedebergs Arch. Pharmakol., 358: 134-139, 1998. (Pubitemid 28365970)
8. Lincoln, T. M., and Cornwell, T. L. Intracellular cyclic GMP receptor proteins. FASEB J., 7: 328-338, 1993. (Pubitemid 23067783)
9. Thompson, W. J., Piazza, G. A., Li, H., Liu, L., Fetter, J., Zhu, B., Sperl, G., Ahnen, D., and Pamukcu, R. Exisulind induction of apoptosis involves guanosine 3′, 5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated β-catenin. Cancer Res., 60: 3338-3342, 2000. (Pubitemid 30482142)
10. 2-terminal kinase 1. Clin. Cancer Res., 6: 4136-4141, 2000.
11. Piazza, G. A., Alberts, D. S., Hixson, L. J., Paranka, N. S., Li, H., Finn, T., Bogert, C., Guillen, J. M., Brendel, K., Gross, P. H., Sperl, G., Ritchie, J., Burt, R. W., Ellsworth, L., Ahnen, D. J., and Pamukcu, R. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res., 57: 2909-2915, 1997. (Pubitemid 27315038)
12. Piazza, G. A., Xu, S., Klein-Szanto, A., Ahnen, D., Liu, L., Li, H., and Thompson, W. J. Overexpression of cGMP phosphodiesterase in colonic neoplasias compared to normal mucosa. Gastroenterology, 118: A282, 2000.
13. min/+ mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res., 60: 5151-5157, 2000.
14. Ruth, P. Cyclic GMP-dependent protein kinases: understanding in vivo functions by gene targeting. Pharmacol. Ther., 82: 355-372, 1999. (Pubitemid 29255930)
15. Halbrügge, M., Friedrich, C., Eigenthaler, M., Schanzenbacher, P., and Walter, U. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP-and cAMP-elevating vasodilators. J. Biol. Chem., 265: 3088-3093, 1990.
16. Reinhard, M., Halbrugge, M., Scheer, U., Wiegand, C., Jockusch, B. M., and Walter, U. The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts. EMBO J., 11: 2063-2070, 1992.
17. Horstrup, K., Jablonka, B., Honig-Liedl, M., Just, M., Kochsiek, K., and Walter, U. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur. J. Biochem., 225: 21-27, 1994. (Pubitemid 24306224)
18. Hauser, W., Knobeloch, K. P., Eigenthaler, M., Gambaryan, S., Krenn, V., Geiger, J., Glazova, M., Rohde, E., Horak, I., Walter, U., and Zimmer, M. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc. Natl. Acad. Sci. USA, 96: 8120-8125, 1999. (Pubitemid 29328418)
19. Massberg, S., Sausbier, M., Klatt, P., Bauer, M., Pfeifer, A., Siess, W., Fassler, R., Ruth, P., Krombach, F., and Hofmann, F. Increased adhesion and aggregation of platelets lacking cyclic guanosine 3′, 5′- monophosphate kinase I. J. Exp. Med., 189: 1255-1264, 1999.
20. Smolenski, A., Bachmann, C., Reinhard, K., Honig-Liedl, P., Jarchau, T., Hoschuetzky, H., and Walter, U. Analysis and regulation of vasodilator- stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J. Biol. Chem., 273: 20029-20035, 1998. (Pubitemid 28377554)
21. Butt, E., Abel, K., Krieger, M., Palm, D., Hoppe, V., Hoppe, J., and Walter, U. cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion protein VASP in vitro and in intact human platelets. J. Biol. Chem., 269: 14509-14517, 1994. (Pubitemid 24194005)
22. Collins, S. P., and Uhler, M. D. Cyclic AMP- and cyclic GMP-dependent protein kinases differ in their regulation of cyclic AMP response element-dependent gene transcription. J. Biol. Chem., 274: 8391-8404, 1999. (Pubitemid 29164627)
23. Gudi, T., Lohmann, S. M., and Pilz, R. B. Regulation of gene expression by cyclic GMP-dependent protein kinase requires nuclear translation of the kinase: identification of a nuclear localization signal. Mol. Cell. Biol., 17: 5244-5254, 1997. (Pubitemid 27357623)
24. Soh, J-W., Lee, E. H., Prywes, R., and Weinstein, I. B. Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Mol. Cell. Biol., 19: 1313-1324, 1999. (Pubitemid 29046873)
25. Piazza, G. A., Rahm, A. K., Finn, T. S., Fryer, B. H., Li, H., Stoumen, A. L., Pamukcu, R., and Ahnen, D. J. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res., 57: 2452-2459, 1997. (Pubitemid 27255906)
26. Takase, Y., Saeki, T., Watanabe, N., Adachi, H., Souda, S., and Saito, I. Cyclic GMP phosphodiesterase inhibitors. II. Requirement of 6-substitution of quinazoline derivatives for potent and selective inhibitory activity. J. Med. Chem., 37: 2106-2111, 1994. (Pubitemid 24233624)
27. Ko, F. N., Wu, C. C., Kuo, S. C., Lee, F. Y., and Teng, C. M. YC-1, a novel activator of platelet guanylate cyclase. Blood, 84: 4226-4233, 1994.
28. McDonald, L. J., and Murad, F. Nitric oxide and cGMP signaling. Adv. Pharmacol., 34: 263-275, 1995.
29. Butt, E., Eigenthaler, M., and Genieser, H. G. (Rp)-8-pCPT-cGMPs, a novel cGMP-dependent protein kinase inhibitor. Eur. J. Pharmacol., 269: 265-268, 1994.
30. Harris, T. E., Persaud, S. J., and Jones, P. M. Pseudosubstrate inhibition of cyclic AMP-dependent protein kinase in intact pancreatic islets: effects on cyclic AMP-dependent and glucose-dependent insulin secretion. Biochem. Biophys. Res. Commun., 232: 648-651, 1997. (Pubitemid 27214051)
31. Shen, Y. H., Wang, X. L., and Wilcken, D. E. Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett., 433: 125-131, 1998. (Pubitemid 28386744)
32. Lim, J. T., Piazza, G. A., Han, E. K., Delohery, T. M., Li, H., Finn, T. S., Buttyan, R., Yamamoto, H., Sperl, G. J., Brendel, K., Gross, P. H., Pamukcu, R., and Weinstein, I. B. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochem. Pharmacol., 58: 1097-1107, 1999. (Pubitemid 29381510)
33. Liu, L., Li, H., Underwood, T., Lloyd, M., David, M., Sperl, G., Pamukcu, R., and Thompson, W. J. Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells. J. Pharmacol. Exp. Ther., 299: 583-592, 2001. (Pubitemid 32979671)
34. Soh, J-W., Mao, Y., Liu, L., Thompson, W. J., Pamukcu, R., and Weinstein, I. B. Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1. J. Biol. Chem., 276: 16406-16410, 2001.
35. Suhasini, M., Li, H., Lohmann, S. M., Boss, G. R., and Pilz, R. B. Cyclic-GMP-dependent protein kinase inhibits the Ras/mitogen-activated protein kinase pathway. Mol. Cell. Biol., 18: 6983-6994, 1998. (Pubitemid 28533019)
36. Smolenski, A., Poller, W., Walter, U., and Lohmann, S. M. Regulation of human endothelial cell focal adhesion sites and migration by cGMP-dependent protein kinase I. J. Biol. Chem., 275: 25723-25732, 2000.